The biotech firm 180 Life Sciences has rebranded as ETHZilla after launching a treasury in Ethereum (ETH) worth $425 million. Therefore, moving its focus to blockchain instead of biotech. The initiative will see the company use Ethereum as a core treasury asset and a standard for on-chain financial strategies. ETHZilla Aims to Become Ethereum Treasury
The post 180 Life Sciences To Launch $425M Ethereum Treasury, Rebrands to ETHZilla appeared first on CoinGape.
